-- Propel Holdings (PRL.TO) 周一公布，尽管营收增长超出分析师预期，但第一季度调整后净利润仍出现下滑，同时提高了股息。 这家数字贷款和金融科技公司表示，剔除大部分一次性项目后，其调整后利润同比下降1.7%至2300万美元，合每股0.54美元，而去年同期为2340万美元，合每股0.55美元。根据FactSet的数据，这一业绩超过了分析师普遍预期的每股0.51美元。 Propel第一季度营收增长20%至1.661亿美元，高于去年同期的1.389亿美元，也超过了FactSet此前预测的1.643亿美元。 该公司还表示，其董事会已将年度股息从每股0.90加元提高至0.96加元，自第二季度起生效，这是该公司连续第十一个季度提高股息。 首席执行官克莱夫·金罗斯表示：“展望未来，我们将继续专注于执行增长战略。我们正在拓展美国其他州的业务，推出新产品，并增加新的营销合作伙伴和渠道，以进一步扩大贷款发放规模，同时利用我们的人工智能平台来支持持续的信贷业绩。我们看到公司业务发展势头强劲。我们有信心在2026年及以后实现持续盈利增长。” 该公司股票在多伦多证券交易所收盘上涨0.49加元，至21.90加元。
Related Articles
Asia
Westpac's Total Capital, CET1 Capital Up Year on Year in March Quarter
Westpac Banking (ASX:WBC, NZE:WBC) total capital and Common Equity Tier 1 (CET1) capital both increased year-over-year in the March quarter, according to a Tuesday Australian bourse filing.The bank's total capital in the three months to March came in at AU$98.54 billion, up from the AU$97.14 billion it reported in the year-ago period. Its CET1 capital for the period clocked in at AU$56.94 billion, rising from the AU$55.01 billion it reported for the March 2025 quarter.Its CET1 ratio for the March quarter was 12.4%, compared with a ratio of 12.2% in the prior-year period. It reported a liquidity coverage ratio of 132% for the quarter, compared with 135% in the same period in the previous year.
$ASX:WBC$NZE:WBC
Research
Research Alert: CFRA Raises Opinion On Shares Of Gildan Activewear To Buy From Hold
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We maintain our 12-month price target of CAD98, based on 16.0x our 2026 EPS estimate and above the company's five-year average forward P/E multiple of 12.9x, reflecting our view that the company deserves an above-peer multiple. We view the recent acquisition of HanesBrands as positive and believe the company will improve Hanes' operating efficiency while capitalizing on significant synergies. GIL reported Q1 2026 results that reflect the significant impact of its HanesBrands acquisition, with revenues increasing 64% to $1.17B, $18M above estimates, while facing substantial integration-related charges. Adjusted EPS from continuing operations declined to $0.43 from $0.59, $0.08 above consensus estimates, reflecting higher share count from the acquisition and ongoing integration expenses. We now view shares more positively after a 20% decline from its 52-week high just a few months ago. Shares currently trade at 13.5x the midpoint of the company's full-year EPS guidance.
$GIL
Asia
Medibank Private Reports Policyholder Growth in Nine Months to March 31, Maintains Outlook
Medibank Private (ASX:MPL) reported policyholder growth of 22,400 in its resident private health insurance business in the nine months to March 31, up 25% from the same period a year earlier, according to a Tuesday filing with the Australian bourse.The company said the resident private health insurance industry has become more competitive in recent months, with data showing consumers increasingly prioritizing value and some participants resorting to price-led customer propositions."While no new material trends have emerged in 2026, Medibank will continue to monitor utilization given historic behavior and competitor activity as we remain disciplined," it said.Medibank maintained its fiscal 2026 guidance, saying it does not expect global events and volatility to have a direct impact on its businesses.The company's main financial exposure is through its investment portfolio, which includes about AU$188 million of investments in equities, and through movements in Australia's cash rate where it flagged a roughly AU$7 million annual impact to investment income.
$ASX:MPL